A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Neurology® Podcast · American Academy of Neurology
July 28, 202515m 38s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.